• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0000
    High 0.0000
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIGNE
Igene Biotechnology Inc
1.6K
0.0x
---
United StatesITRO
Itronics Inc
20.0
0.0x
---
United StatesHUMT
Humatech Inc
100.0
0.0x
---
United StatesGREN
Greensmart Corp
40.0
0.0x
---
United StatesSNES
Senestech Inc
1.3M
0.0x
---
United StatesSNRG
Susglobal Energy Corp
3.0M
-1.0x
---
As of 2024-11-05

Company Information

IGENE Biotechnology, Inc. (Igene) is focused on the research, development, production and commercialization of specialty ingredients for human and animal nutrition. The Company develops, produces and markets specialty biochemical products. It is a supplier of natural astaxanthin, a nutrient in different feed applications and a source of pigment for coloring farmed salmon species. Igene provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, to commercial sized fermentors. It also provides analytical chemistry services for identification and quantization of carotenoids in foods, feeds, and animal tissues, including verification of wild versus farm raised salmonids. Within animal nutrition, the Company focus is to deliver astaxanthin to the fish feed market.

Contact Information

Headquarters
9110 Red Branch Rd, Suite JCOLUMBIA, MD, United States 21045-2024
Phone
410-997-2599
Fax
410-730-0540

Executives

Chairman of the Board
Michael Kimelman
President, Chief Technical Officer, Treasurer, Director of R&D, Director
Stephen Hiu
Vice Chairman of the Board
Thomas Kempner
Chief Financial Officer
Edward Weisberger
Vice President, Secretary, Director of Manufacturing, Director
Patrick Monahan

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.6K
Revenue (TTM)
$3.9K
Shares Outstanding
1.6B
Igene Biotechnology Inc does not pay a dividend.
Beta
---
EPS
$0.00
Book Value
$0.00
P/E Ratio
0.0x
Price/Sales (TTM)
0.4
Price/Cash Flow (TTM)
---
Operating Margin
-59,804.36%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.